Bayer Seeks New Indication Approval for Kerendia in China
Bayer Submits New Drug Application in China to Expand Finerenone Use for Adults with Non-Diabetic Chronic Kidney Disease Bayer has announced the submission of a New Drug Application (NDA) to…
Read MoreBayer Seeks New Indication Approval for Kerendia in China
Novo Nordisk Shares Update on Phase 3 ZEUS Trial
Novo Nordisk Reports Topline Results from Phase 3 ZEUS Trial Evaluating Ziltivekimab for Cardiovascular Risk Reduction Novo Nordisk has announced topline findings from its pivotal Phase 3 ZEUS cardiovascular outcomes…
EU Approves Datroway® for First-Line Metastatic TNBC Treatment
EU Approval Positions Datroway® as the Only TROP2-Targeted Therapy with Overall Survival Benefit in First-Line Metastatic TNBC The European Commission (EC) has approved Datroway® (datopotamab deruxtecan) as a monotherapy for…
Polpharma Biologics Secures FDA and EMA Review for PB016 Biosimilar
Polpharma Biologics’ Vedolizumab Biosimilar PB016 Accepted for FDA and EMA Review, Advancing Access to Biologic Therapy for Inflammatory Bowel Disease Polpharma Biologics International AG has announced that its proposed vedolizumab…
PHC Launches Cell-IQ® CO₂ Incubators with Advanced Humidity Control
PHC Corporation of North America Launches Cell-IQ® CO₂ Incubator Series with Advanced Humidity Control and Contamination Prevention PHC Corporation of North America (PHCNA), a leading provider of PHCbi laboratory equipment…
Contineum Therapeutics Announces Second-Quarter 2026 Financial Results
Contineum Therapeutics Reports Second Quarter 2026 Financial Results and Reaffirms Clinical Development Milestones Across Inflammatory and Fibrotic Disease Pipeline Contineum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing differentiated…
CareDx Announces Q2 2026 Financial Performance
CareDx Reports Strong Second Quarter 2026 Results with 52% Revenue Growth and Raises Full-Year Financial Outlook CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnostics company focused on transplant medicine,…
Meitheal Pharmaceuticals Receives FDA Approval for Garzulys™ Injection
Meitheal Pharmaceuticals Secures FDA Approval for Garzulys™ Biosimilar Insulin to Expand Diabetes Care in the U.S. Meitheal Pharmaceuticals, Inc., a Chicago-based biopharmaceutical company focused on the development and commercialization of…
PVP Labs to Showcase Taphalgin® at 2026 Military Health System Research Symposium
PVP Labs to Present Taphalgin® Research at 2026 Military Health System Research Symposium, Highlighting a Novel Battlefield Pain Management Approach PVP Labs, a clinical-stage biotechnology company focused on developing innovative…
Feinstein Institutes Scientists Discover the Brain’s Breathing Alarm System
Feinstein Institutes Researchers Discover the Brain’s Respiratory Alarm Mechanism Researchers at Northwell Health’s Feinstein Institutes for Medical Research have uncovered a previously unknown brain circuit that continuously monitors every breath…
miRecule and Rio Biopharma Partner to Advance Targeted RNA Therapeutics
miRecule and Rio Biofarma Brasil Partner to Advance Next-Generation RNA Delivery Technologies miRecule, Inc., a biotechnology company focused on developing next-generation RNA therapeutics for rare genetic diseases, has entered into…
Cofactor Genomics Appoints Dr. Howard Bailey as Chief Medical Officer
Cofactor Genomics Appoints Renowned Oncologist Dr. Howard H. Bailey as Chief Medical Officer to Advance Precision Immunotherapy Diagnostics Cofactor Genomics, a commercial-stage diagnostics company focused on advancing precision oncology through…